1 / 5

Worldwide Companion Diagnostics Market 2020-2025 Growth, Trends and Demands Research Report

Increase in burden of cancer globally, growing demand for personalized medicine and targeted therapy coupled with increase in adoption of drug diagnostics co-development model by industry players are the key factors driving the global companion diagnostics market.

DamonGillespie
Download Presentation

Worldwide Companion Diagnostics Market 2020-2025 Growth, Trends and Demands Research Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Adroit Market Research Companion Diagnostics Market Companion Diagnostics Market Size 2018, By Products & Services (Assays, Kits & Reagents, Software & Services), By Technology (Polymerase Chain Reaction (PCR), Next- Generation Sequencing (NGS), In Situ Hybridization (ISH), Immunohistochemistry (ICH), Others), By Application (Cancer, Cardiovascular Diseases, Infectious Diseases, Neurological Diseases, Others), By Region and Forecast 2019 to 2025 Single Use License: US$ 4400 Request Sample +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  2. Adroit Market Research Companion Diagnostics Market Companion Diagnostics Market Size and Share 2025 Size and Share 2025 • The global companion diagnostics market is projected to reach an approximate value of USD 9.2 billion by 2025, growing at a CAGR of 14.2%. Increasing demand for personalized medicine, rise in incidence of cancer, increasing investments in R&D for the development of biomarkers and companion diagnostics tests are factors driving the global companion diagnostics market. • Adroit Market Research report on global companion diagnostics market gives a holistic view of the market from 2015 to 2025, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2015 to 2017, with the base year of estimation as 2018 and forecast from 2019 to 2025. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the market based on Porter's five forces analysis and positions the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global companion diagnostics market have been studied in detail. • Companion diagnostics (CDx) are tests that are developed alongside drugs in the drug development process in order to determine whether or not the patient is a candidate for the particular therapy. Such tests are increasingly found in the oncology field where the use of very expensive therapies is at stake. There is rapid adoption of companion diagnostic tests in clinical laboratories owing to increase in collaborations between pharmaceutical and diagnostic companies for the development of companion diagnostic tests, which is likely to escalate the growth of the market. For instance, EGFR for lung cancer, KRAS for colon cancer, BCR-ABL for chronic myelogenous leukemia and BRAF for melanoma are some of the major companion diagnostic tests available in the market for tumor detection. +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  3. Adroit Market Research Companion Diagnostics Market Companion Diagnostics Market Size and Share 2025 Size and Share 2025 • The global companion diagnostics market has been segmented based on products & services, application, technology, and region. Based on products & services, the global companion diagnostics market is categorized into assays, kits & reagents, and software & services. On the basis of application, the global companion diagnostics market is segmented into cancer, neurological diseases, infectious diseases, cardiovascular diseases, and others. Cancer held majority of the market share in 2018. Technology-wise, the global companion diagnostics market is segregated into polymerase chain reaction (PCR), next- generation sequencing (NGS), immunohistochemistry (ICH), in situ hybridization (ISH), and others. • Geographically, North America dominated the global companion diagnostics market in 2018. Wide availability of companion diagnostics tests and services, favourable reimbursement scenario, increase in volume of clinical trials and drug approval rates, presence of well-established healthcare facilities, and high prevalence of cancer in the region are key factors likely to drive the growth of the market in the next few years. • Major players operating in the global companion diagnostics market include Qiagen N.V., F. Hoffmann-La Roche, Agilent Technologies Inc., Pfizer, Abbott Laboratories, AstraZeneca, Thermo Fisher Scientific, bioMérieux SA, Myriad Genetics, and Illumina, Inc. among others. +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  4. Adroit Market Research Companion Diagnostics Market Companion Diagnostics Market Size and Share 2025 Size and Share 2025 Key Segments of the Global Companion Diagnostics Market Products & Services Overview, 2015-2025 (USD Million) • Assays, Kits & Reagents • Software & Services Application Overview, 2015-2025 (USD Million) • Cancer • Lung Cancer • Breast Cancer • Colorectal Cancer • Melanoma • Leukemia • Others • Infectious Diseases • Cardiovascular Diseases • Neurological Diseases • Others +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  5. Adroit Market Research About Us About Us Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps. Our analysts have tracked high growth markets in chemicals & materials, healthcare & pharmaceuticals, semiconductor & electronics, energy & power, food & retail, consumer goods, technology, and machinery & equipment sectors across the world to identify new opportunities, potential customers, prepare go-to-market (GTM) strategies, identify segments for revenue growth for companies, and many more. Contact Us US Headquarters Phone: +1 (214) 884-6068 Email: sales@adroitmarketresearch.com 3131 McKinney Ave Ste 600 Dallas, TX 75204 ,U.S.A +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

More Related